Supplementary Table 2 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC
<p>Information of ATCC cell lines</p>
में बचाया:
| मुख्य लेखक: | |
|---|---|
| अन्य लेखक: | , , , , , , , , , , , |
| प्रकाशित: |
2025
|
| विषय: | |
| टैग: |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|
| _version_ | 1849927634232803328 |
|---|---|
| author | Seung Yeon Oh (15051017) |
| author2 | You Won Lee (15051020) Eun Ji Lee (15051023) Jae Hwan Kim (15051026) YoungJoon Park (15051029) Seong Gu Heo (15032490) Mi Ra Yu (15051032) Min Hee Hong (15014541) John DaSilva (15051035) Christopher Daly (15030374) Byoung Chul Cho (15032496) Sun Min Lim (15051038) Mi Ran Yun (15032484) |
| author2_role | author author author author author author author author author author author author |
| author_facet | Seung Yeon Oh (15051017) You Won Lee (15051020) Eun Ji Lee (15051023) Jae Hwan Kim (15051026) YoungJoon Park (15051029) Seong Gu Heo (15032490) Mi Ra Yu (15051032) Min Hee Hong (15014541) John DaSilva (15051035) Christopher Daly (15030374) Byoung Chul Cho (15032496) Sun Min Lim (15051038) Mi Ran Yun (15032484) |
| author_role | author |
| dc.creator.none.fl_str_mv | Seung Yeon Oh (15051017) You Won Lee (15051020) Eun Ji Lee (15051023) Jae Hwan Kim (15051026) YoungJoon Park (15051029) Seong Gu Heo (15032490) Mi Ra Yu (15051032) Min Hee Hong (15014541) John DaSilva (15051035) Christopher Daly (15030374) Byoung Chul Cho (15032496) Sun Min Lim (15051038) Mi Ran Yun (15032484) |
| dc.date.none.fl_str_mv | 2025-11-25T12:43:53Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30705987 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Supplementary_Table_2_from_Preclinical_Study_of_a_Biparatopic_METxMET_Antibody_Drug_Conjugate_REGN5093-M114_Overcomes_MET-driven_Acquired_Resistance_to_EGFR_TKIs_in_EGFR-mutant_NSCLC/30705987 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Therapeutic Research and Development Drug Resistance Clinical drug resistance Lung Cancer Translational Research |
| dc.title.none.fl_str_mv | Supplementary Table 2 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Information of ATCC cell lines</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_18f838363cdc8dd0fa691306b02428a2 |
| identifier_str_mv | 10.1158/1078-0432.30705987 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30705987 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Table 2 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLCSeung Yeon Oh (15051017)You Won Lee (15051020)Eun Ji Lee (15051023)Jae Hwan Kim (15051026)YoungJoon Park (15051029)Seong Gu Heo (15032490)Mi Ra Yu (15051032)Min Hee Hong (15014541)John DaSilva (15051035)Christopher Daly (15030374)Byoung Chul Cho (15032496)Sun Min Lim (15051038)Mi Ran Yun (15032484)CancerTherapeutic Research and DevelopmentDrug ResistanceClinical drug resistanceLung CancerTranslational Research<p>Information of ATCC cell lines</p>2025-11-25T12:43:53ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30705987https://figshare.com/articles/dataset/Supplementary_Table_2_from_Preclinical_Study_of_a_Biparatopic_METxMET_Antibody_Drug_Conjugate_REGN5093-M114_Overcomes_MET-driven_Acquired_Resistance_to_EGFR_TKIs_in_EGFR-mutant_NSCLC/30705987CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307059872025-11-25T12:43:53Z |
| spellingShingle | Supplementary Table 2 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC Seung Yeon Oh (15051017) Cancer Therapeutic Research and Development Drug Resistance Clinical drug resistance Lung Cancer Translational Research |
| status_str | publishedVersion |
| title | Supplementary Table 2 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC |
| title_full | Supplementary Table 2 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC |
| title_fullStr | Supplementary Table 2 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC |
| title_full_unstemmed | Supplementary Table 2 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC |
| title_short | Supplementary Table 2 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC |
| title_sort | Supplementary Table 2 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC |
| topic | Cancer Therapeutic Research and Development Drug Resistance Clinical drug resistance Lung Cancer Translational Research |